| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0272-6386(12)80136-3 |
| P698 | PubMed publication ID | 8203365 |
| P2093 | author name string | Wang J | |
| Vaziri ND | |||
| Said S | |||
| Gonzales EC | |||
| P2860 | cites work | Nephrotic syndrome and coagulation and fibrinolytic abnormalities | Q33477949 |
| Coagulation abnormalities in patients with end-stage renal disease treated with hemodialysis. | Q33478985 | ||
| Regulation of fibrinogen synthesis by plasmin-derived fragments of fibrinogen and fibrin: an indirect feedback pathway | Q36285065 | ||
| Central Retinal Vein Occlusion Associated with Hemodialysis | Q41474795 | ||
| Prothrombin Time after Heparin Removal: Application to Monitoring Simultaneous Anticoagulation with Heparin and Coumarins | Q41660510 | ||
| Coagulation cascade, fibrinolytic system, antithrombin III, protein C and protein S in patients maintained on continuous ambulatory peritoneal dialysis | Q44285052 | ||
| Coagulation, fibrinolytic, and inhibitory proteins in acute myocardial infarction and angina pectoris | Q46183387 | ||
| Effect of Hemodialysis on Protein C, Protein S, and Antithrombin III Levels | Q67897301 | ||
| Enhanced coagulation-fibrinolysis in patients on regular hemodialysis treatment | Q67901616 | ||
| Dynamic fluctuations in blood of thrombin/antithrombin III complex (TAT) | Q68058451 | ||
| Hemostatic disturbances induced by two hollow-fiber hemodialysis membranes | Q68147587 | ||
| Comparison of two hemodialysis membranes, polyacrylonitrile and cellulose acetate, on complement and coagulation systems | Q68421868 | ||
| Activation of platelets, coagulation and fibrinolysis in patients on long-term haemodialysis: influence of cuprophan and polyacrylonitrile membranes | Q68423215 | ||
| Comprehensive study of haemostasis in chronic uraemia | Q70429071 | ||
| Effect of hemodialysis on contact group of coagulation factors, platelets, and leukocytes | Q70606902 | ||
| Complications of renal dialysis access procedures | Q70666776 | ||
| Fibrinogen as a risk factor for stroke and myocardial infarction | Q71438059 | ||
| Factor VIII activity in chronic renal disease | Q71575642 | ||
| Haemostatic function and cardiovascular death: early results of a prospective study | Q72423400 | ||
| The partial thromboplastin time with kaolin. A simple screening test for first stage plasma clotting factor deficiencies | Q78981048 | ||
| Electroimmuno assay | Q93725185 | ||
| P433 | issue | 6 | |
| P921 | main subject | kidney disease | Q1054718 |
| P304 | page(s) | 828-835 | |
| P577 | publication date | 1994-06-01 | |
| P1433 | published in | American Journal of Kidney Diseases | Q4744250 |
| P1476 | title | Blood coagulation, fibrinolytic, and inhibitory proteins in end-stage renal disease: effect of hemodialysis | |
| P478 | volume | 23 |
| Q48035015 | A novel factor for primary arteriovenous fistula failure: hyperinsulinism |
| Q73154033 | Abnormalities of coagulation in hypertensive patients with reduced creatinine clearance |
| Q41225267 | Blood coagulation system in patients with chronic kidney disease: a prospective observational study |
| Q37454373 | Cardiovascular risk and management in chronic kidney disease |
| Q44455281 | Clinical Outcome of Preemptive Kidney Transplantation in Patients With Diabetes Mellitus |
| Q37418963 | Coagulation factors as biological risk markers of endothelial dysfunction. Association with the thrombotic episodes of chronic hemodialysis patients |
| Q38401394 | Coagulation profile in patients with chronic kidney disease before and after kidney transplantation: A retrospective cohort study. |
| Q38464975 | Considerations for Systemic Anticoagulation in ESRD. |
| Q31965305 | Does renal failure cause an atherosclerotic milieu in patients with end-stage renal disease? |
| Q28081493 | Early renal failure as a cardiovascular disease: Focus on lipoprotein(a) and prothrombotic state |
| Q42878421 | Effects of L-Carnitine supplement on plasma coagulation and anticoagulation factors in hemodialysis patients |
| Q42878436 | Effects of omega-3 on lipid profile and inflammation markers in peritoneal dialysis patients |
| Q34927281 | Elevated levels of procoagulant plasma microvesicles in dialysis patients. |
| Q33374743 | Essentials of anticoagulation in hemodialysis |
| Q44748019 | Evaluation of the coagulation and inflammatory responses in solid organ transplant recipients and donors |
| Q58950361 | Fibrinogen, mortality and incident cardiovascular complications in end-stage renal failure |
| Q39003917 | Filtering Out Use of DOACs in Hemodialysis |
| Q57718697 | Gene expression profiling in the remnant kidney model of wild type and kinin B1 and B2 receptor knockout mice |
| Q40957186 | Hemodialyzer performance: biological indices |
| Q44929573 | Hemostatic disturbances in patients with systemic inflammatory response syndrome (SIRS) and associated acute renal failure (ARF). |
| Q70976482 | Heparinization for routine hemodialysis |
| Q35173882 | Impact of low-dose urokinase in peritoneal dialysis on serum oxidative stress, nitric oxide and endothelin in cerebral infarction complicated with uremia |
| Q47796229 | Incidence of arteriovenous thrombosis and the role of anticardiolipin antibodies in hemodialysis patients |
| Q73006796 | Plasminogen activator inhibitor-1 activity in chronic renal disease and dialysis |
| Q46665619 | Platelet (dys)function and plasma plasminogen levels in hemodialysis patients |
| Q62588858 | Relationship between oxidative stress and extrinsic coagulation pathway in haemodialyzed patients |
| Q64098461 | Retention of beneficial molecules and coagulation factors during haemodialysis and haemodiafiltration |
| Q53143940 | Risk factors for early hemorrhagic and thrombotic complications after kidney transplantation. |
| Q51133330 | Successful treatment of the chronically thrombosed dialysis access graft: resuscitation of dead grafts. |
| Q85089565 | The effect of cause of cadaveric kidney donors death on fibrinolysis and blood coagulation processes |
| Q49815468 | The hypercoagulability paradox of chronic kidney disease: The role of fibrinogen |
| Q78772918 | Usefulness of atrial fibrillation as a marker of outcome after percutaneous coronary intervention |
| Q36558741 | Vascular access thrombosis prophylaxis |
Search more.